Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes

Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells

(2015) Yang Yang et al.   Oncotarget

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

(2014) Luca Faloppi et al.   BMC CANCER

Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients

(2014) Shuai Wang et al.   CLINICA CHIMICA ACTA

Serum Carcinoembryonic Antigen Levels and the Risk of Whole-body Metastatic Potential in Advanced Non-small Cell Lung Cancer

(2014) Dong Soo Lee et al.   Journal of Cancer

Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of Metastasis

(2013) Dong Soo Lee et al.   Cancer Research and Treatment

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

(2012) M Scartozzi et al.   BRITISH JOURNAL OF CANCER

The relevance of serum carcinoembryonic antigen as an indicator of brain metastasis detection in advanced non-small cell lung cancer

(2012) Dong-Soo Lee et al.   TUMOR BIOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy

(2011) M. I. Koukourakis et al.   CLINICAL CANCER RESEARCH

Erlotinib Monotherapy for Stage IIIB/IV Non-small Cell Lung Cancer: A Multicenter Trial by the Korean Cancer Study Group

(2010) Ji Eun Uhm et al.   Journal of Thoracic Oncology

Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer

(2010) Neeta Somaiah et al.   Journal of Thoracic Oncology

The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer

(2009) Krzysztof Konopa et al.   CURRENT DRUG TARGETS